Catecholamine refractoriness and their mechanisms in cardiocirculatory shock and chronic heart failure

Thoracic and Cardiovascular Surgeon

Volumn 46, Issue 2 SUPPL., 1998, Pages 270-276

  Bohm M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Adenylyl cyclase; Cardiogenic shock; G proteins; Heart failure; Septic shock; adrenoceptors

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC SYSTEM; CARDIOGENIC SHOCK; CONGESTIVE HEART FAILURE; HUMAN; METABOLISM; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADENYLATE CYCLASE; CATECHOLAMINES; GTP-BINDING PROTEINS; HEART FAILURE, CONGESTIVE; HUMANS; RECEPTORS, ADRENERGIC, BETA; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SHOCK, CARDIOGENIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 0032150458     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013084     Document Type: Article

References (16)

1. Cohn JN: The sympathetic nervous system in heart failure. J Cardiovasc Pharmacol. 1989;14(Suppl 5):57-61.
2. Bayliss J, Norell M, Capena-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-21.
3. Dzau V, Colucci W, Hollenberg N, Williams G. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645-56.
4. Gilman AG. G-proteins: transducers of receptor-generated signals. Ann Rev Biochem. 1987;56:615-49.
5. Birnbaumer L. G-proteins in signal transduction. Annu Rev Pharmacol Toxicol. 1990;30:675-705.
6. Simon MI, Strathmann MP, Gautam N. Diversity of G-proteins in signal transduction. Science. 1991;252:802-8.
7. 2 by G-protein βγ-subunits. Nature. 1992;360:684-6.
8. Tang WJ, Gilman AC. Type-specific regulation of adenylyl cyclase by G-protein βγ-subunits. Science. 1991;254:1500-03.
9. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-23.
10. Francis GS, Goldsmith SR, Ziesche SM, Cohn JN. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol. 1982;49: 1152-59.
11. Swedberg K, Viquerat C, Rouleau JL, Roizen M, Atherton B, Parmley WW, Chatterjee K. Comparision of myocardial catecholamine balance in chronic congestive heart failure and in angina pectoris without failure. Am J Cardiol. 1984;54:783-9.
12. Bristow MR, Anderson FL, Port DP, Skerl L, Hershberger RS, Larabee P, O'Conell JB, Renlund DC, Volkman K, Murray J, Feldman AM. Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:1024-39.
13. Böhm M, La Rosée K, Schwinger RHG, Erdmann E. Evidence for a reduction or norephinephrine uptake sites in the failing human heart. J Am Coll Cardiol. 1995;25:146-53.
14. 2-receptors of human hearts. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol. 1985;331:60-70.
15. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: Desensitization of β-adrenergic receptor function. FASEB J. 1990;4:2881-89.
16. Lohse MJ. Mechanisms of β-adrenergic receptor desensitization. In: Hargave PA, Hofmann KP, Kaupp UB, eds. Signal Transmission in Photoreceptor Systems. Berlin, Heidelberg, New York: Springer; 1992:160-71.